I received two 40‑mg intra‑articular cortisone injections (one in each knee) 36 hours ago; my overnight blood glucose is around 300 mg/dL while using insulin glargine (Lantus) 18 U daily with a carbohydrate‑to‑insulin ratio of 1 U per 12 g carbs and a high correction factor—should I increase the basal insulin dose, tighten the carb ratio, and adjust the correction factor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Insulin Adjustment for Cortisone‑Induced Hyperglycemia

Increase your Lantus dose immediately to 24–26 units (a 33–44% increase from 18 units) and tighten your carbohydrate ratio to 1:8–1:10 grams while increasing your correction scale by 50% to manage the transient hyperglycemia caused by intra‑articular corticosteroid injections.

Understanding Cortisone‑Induced Hyperglycemia

  • Intra‑articular corticosteroid injections cause acute hyperglycemia lasting 2–7 days, with peak glucose elevations typically occurring 24–72 hours post‑injection and values reaching as high as 300–500 mg/dL in patients with diabetes 1, 2, 3.
  • The hyperglycemic effect is transient and self‑limited, resolving within 1 week as the steroid is absorbed and metabolized 2, 3.
  • Your current overnight glucose readings in the 300s mg/dL range are consistent with the expected peak effect occurring 36 hours after receiving 80 mg total triamcinolone (40 mg per knee) 2, 3.

Immediate Basal Insulin Adjustment

  • Increase Lantus from 18 units to 24–26 units once daily (approximately 33–44% increase) to counter the steroid‑induced insulin resistance 4, 5.
  • This aggressive upfront increase is necessary because corticosteroids typically require 40–60% higher insulin doses than baseline to maintain glycemic control 4, 5.
  • Administer the increased Lantus dose at your usual time (typically bedtime) to provide 24‑hour basal coverage 6.
  • Do not delay this adjustment; the hyperglycemia you are experiencing (300s mg/dL) warrants immediate intervention rather than gradual titration 4.

Carbohydrate Ratio Adjustment

  • Tighten your carbohydrate‑to‑insulin ratio from 1:12 to 1:8–1:10 grams (approximately 20–50% increase in prandial insulin) to adequately cover meals during the steroid effect 5.
  • This means you will now give 1 unit of rapid‑acting insulin for every 8–10 grams of carbohydrate instead of every 12 grams 5.
  • For example, a 60‑gram carbohydrate meal that previously required 5 units (60÷12) will now require 6–7.5 units (60÷10 or 60÷8) 5.

Correction Scale Adjustment

  • Increase your correction insulin doses by approximately 50% to address the elevated glucose readings 4, 5.
  • If your current "high correction scale" provides 1 unit for every 50 mg/dL above target, temporarily adjust to 1 unit for every 30–40 mg/dL above target 4.
  • Use the following simplified correction protocol in addition to your scheduled prandial insulin 4:
    • Pre‑meal glucose 201–250 mg/dL → add 2 units rapid‑acting insulin
    • Pre‑meal glucose 251–350 mg/dL → add 4 units rapid‑acting insulin
    • Pre‑meal glucose >350 mg/dL → add 6 units and contact your provider

Monitoring Protocol

  • Check blood glucose every 2–4 hours for the first 48 hours after implementing these adjustments to identify patterns and prevent hypoglycemia 4, 5.
  • Measure glucose before each meal, 2 hours after meals, at bedtime, and upon waking to guide further dose adjustments 4.
  • Target a fasting glucose of 80–130 mg/dL and daytime glucose of 140–180 mg/dL during this acute period 4.

Tapering Protocol (Days 4–7)

  • Begin reducing insulin doses on day 4–5 as the steroid effect wanes and glucose values start normalizing 5, 3.
  • Reduce Lantus by 2 units every 2–3 days once fasting glucose consistently falls below 130 mg/dL 4, 5.
  • Return to your original 1:12 carbohydrate ratio once pre‑meal glucose readings stabilize in the 100–150 mg/dL range 5.
  • Resume your baseline correction scale when daytime glucose values no longer exceed 200 mg/dL 4.
  • By day 7–10, you should be back to your pre‑injection insulin regimen of Lantus 18 units with 1:12 carb ratio 2, 3.

Hypoglycemia Prevention

  • If any glucose reading falls <70 mg/dL, immediately reduce the implicated insulin dose by 10–20% without waiting 4, 5.
  • Treat hypoglycemia with 15 grams of fast‑acting carbohydrate (4 glucose tablets or 4 oz juice), recheck in 15 minutes, and repeat if needed 4.
  • The risk of hypoglycemia is highest between days 5–7 as the steroid effect resolves but insulin doses remain elevated; close monitoring during this transition is critical 5, 3.

Critical Pitfalls to Avoid

  • Do not maintain your baseline insulin doses when glucose consistently exceeds 250 mg/dL; this reactive approach is inadequate for steroid‑induced hyperglycemia 4, 5.
  • Do not rely solely on correction insulin without adjusting your scheduled basal and prandial doses; correction doses must supplement, not replace, scheduled insulin 4.
  • Do not delay dose reductions once the steroid effect begins to wane (typically day 4–5); failure to taper insulin as glucose normalizes is the most common cause of hypoglycemia in this setting 5, 3.
  • Never use rapid‑acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk 4.

When to Contact Your Provider

  • If glucose remains >300 mg/dL after 48 hours despite the above adjustments 4.
  • If you experience any glucose <70 mg/dL that does not respond to 15 grams of carbohydrate within 15 minutes 4.
  • If you develop nausea, vomiting, or abdominal pain with glucose >250 mg/dL (possible ketoacidosis) 4.
  • If you are uncertain about dose adjustments or experience wide glucose variability (swings >100 mg/dL between readings) 4.

Expected Clinical Outcomes

  • With these adjustments, your overnight glucose should fall to 140–180 mg/dL within 24–48 hours and normalize to <130 mg/dL by day 5–7 4, 3.
  • The total duration of hyperglycemia is typically 5–7 days, with complete resolution by day 10 in most patients 2, 3.
  • Properly implemented dose adjustments do not increase overall hypoglycemia risk when tapered appropriately as the steroid effect resolves 4.

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the appropriate Lantus (glargine) dose and insulin regimen for a patient with a hemoglobin A1c (HbA1c) of 13.1%, transitioning off an insulin drip, with a body mass index (BMI) of 38 and impaired renal function (creatinine 0.77), who is new to insulin therapy?
Is 80 units of Lantus (insulin glargine) daily a safe and effective dose for a patient?
What adjustments should be made to the treatment plan for a patient with uncontrolled hyperglycemia on Lantus (insulin glargine) 12 units?
Is it better to administer 54 units of Lantus (insulin glargine) once daily or twice daily?
What is the next best treatment for an elderly male patient with uncontrolled diabetes mellitus, currently on metformin (biguanide) 1,000 mg twice daily, Januvia (sitagliptin) 100 mg, and Lantus (insulin glargine) 10 units with recent dose increases, who has a history of recurrent yeast infections with Farxiga (dapagliflozin) and presents with hyperglycemia, specifically fasting blood sugar levels of 150-200 mg/dL?
When should metformin be initiated in a pre‑diabetic adult (< 60 years, BMI ≥ 35 kg/m², fasting plasma glucose > 110 mg/dL or HbA1c ≥ 6.0 %, history of gestational diabetes or strong family history, who has not achieved adequate control with lifestyle modification)?
What are the recommended first‑line pharmacologic treatments for urinary urgency in an adult?
What is the first‑line treatment for ringworm (tinea corporis, tinea cruris, tinea pedis, or tinea capitis) in an otherwise healthy adult with localized skin lesions?
Can Procardia (nifedipine) 20 mg be used safely as a tocolytic in a patient with a blood pressure of 115/74 mm Hg?
What is the appropriate treatment approach for a hiatal hernia, including lifestyle modifications, medications, and indications for surgery?
What is the recommended surveillance protocol (imaging, laboratory tests, and physical examination) and duration for a patient who has undergone definitive therapy for renal cell carcinoma, including differences for low‑risk (stage I–II) versus high‑risk (stage III–IV) disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.